Hepion Pharmaceuticals, Inc.
HEPA
$0.07
-$0.02-18.82%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 38.27% | -65.00% | -97.25% | -92.24% | -93.07% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -53.05% | -25.49% | -55.32% | -27.81% | 50.28% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -17.82% | -59.05% | -90.77% | -83.40% | -83.27% |
|
|
|||||
| Total Current Assets | -17.82% | -59.05% | -90.77% | -83.40% | -83.27% |
| Net Property, Plant & Equipment | -- | -- | -100.00% | -58.29% | 147.86% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -74.43% | -22.89% |
| Total Assets | -25.04% | -60.48% | -91.08% | -85.14% | -83.53% |
|
|
|||||
| Total Accounts Payable | -61.32% | -83.75% | -90.63% | -93.80% | -89.35% |
| Total Accrued Expenses | -87.07% | -79.02% | -98.64% | -89.48% | -87.94% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | 5.08% | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -39.23% | -63.64% | -40.57% | -57.58% | -87.29% |
|
|
|||||
| Total Current Liabilities | -39.23% | -63.64% | -40.57% | -57.58% | -87.29% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -92.14% | -74.60% | -93.86% | -39.21% | -40.02% |
| Total Liabilities | -71.06% | -71.39% | -67.85% | -53.40% | -75.83% |
|
|
|||||
| Common Stock & APIC | 5.89% | 5.50% | 1.72% | 2.67% | 2.42% |
| Retained Earnings | -5.86% | -7.23% | -5.87% | -10.63% | -13.97% |
| Treasury Stock & Other | 115.43% | -9.78% | 110.53% | 42.71% | 38.65% |
| Total Common Equity | 12.59% | -62.22% | -163.71% | -114.53% | -92.44% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | 12.59% | -62.22% | -163.71% | -114.53% | -92.44% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 6.60% | -48.20% | -125.59% | -102.52% | -86.49% |
|
|
|||||